Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Oncologist. 2020 Apr;25(4):279-280. doi: 10.1634/theoncologist.2020-0015. Epub 2020 Feb 20.
Opinions vary on the value of geriatric assessments prior to high‐risk therapy for older adults with cancer. This commentary focuses on whether the higher risk of poor outcomes for older patients with cancer can be mitigated by interventions aimed at detecting age‐related impairments.
对于癌症高危治疗前的老年评估的价值,人们的看法不一。本评论重点探讨了针对癌症老年患者的与年龄相关的功能障碍检测的干预措施是否可以降低这些患者不良预后的风险。